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Background: Gastric epithelial dysplasia (GED) can be morphologically categorized into adenomatous and foveolar
types. To date, there have been few studies on the clinical characteristics of GEDs according to the morphologic
types. Therefore, we here aimed to elucidate the clinicopathologic characteristics of patients with GED and the
long-term follow-up results after endoscopic resection according to the morphologic characteristics of GEDs.
Methods: A total of 357 patients who underwent endoscopic resection for GEDs at Pusan National University Hospital
between January 2008 and December 2009 were included in the study. GEDs were morphologically categorized into
adenomatous, foveolar, and hybrid types on histologic examination. The clinicopathologic characteristics of patients
with GEDs and outcomes of endoscopic resection were analyzed.
Results: Patients with GED were divided into 3 groups: adenomatous (n = 167, 46.8%), foveolar (n = 103, 28.9%), and
hybrid (n = 87, 24.3%) types. Compared to the adenomatous type, foveolar type lesions were more frequently located
in the antrum/pylorus, flat/depressed lesions, and normal/reddish in color; and showed more frequent high-grade
dysplasia. During the follow–up period (median, 37.3 months), the overall incidence of synchronous and metachronous
lesions was 20.8% and 20.1%, respectively; of these, the incidence of synchronous and metachronous gastric
cancer was 8.7% and 5.4%, respectively. There were no significant differences in the incidence of synchronous
and metachronous lesions according to morphologic types.
Conclusion: GEDs appear to have different clinicopathologic characteristics according to morphologic types.
Irrespective of the morphology, synchronous and metachronous gastric cancers are commonly found after
endoscopic resection of GEDs. Therefore, close follow-up surveillance after endoscopic resection of GEDs
should be performed for all patients.
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Gastric epithelial dysplasia (GED) is an unequivocal neo-
plastic non-invasive proliferation widely accepted as a
precursor to gastric adenocarcinomas [1]. The frequency
of GED markedly increases with age, especially in patients
in their fifth decade of life and above. This tendency may* Correspondence: doc0224@pusan.ac.kr
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unless otherwise stated.be related to atrophic changes, and especially intestinal
metaplasia of the gastric mucosa, among elderly people
[2-4]. The prevalence of GED shows considerable geo-
graphic differences, with rates between 0.5% and 3.8% ob-
served in western countries, as compared in to between
9% and 20% in regions with a high prevalence of gastric
cancer [5-7]. In addition, the prevalence of GED has been
clearly shown to be associated with the regional preva-
lence of Helicobacter pylori infection [8].
GED, which encompasses gastric adenoma, is a relatively
common disease entity in Korea. GED lies histologicallyis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Baek et al. BMC Gastroenterology  (2015) 15:17 Page 2 of 9and clinically on the borderline of benign and malignant
lesions, and its natural history is still unclear. Therefore,
there is currently no specific treatment policy for GEDs,
and the treatments vary from close endoscopic follow-up
to endoscopic resection. However, GEDs have been previ-
ously demonstrated to represent a penultimate state of
gastric carcinogenesis, and to be indicators of an increased
risk of synchronous adenocarcinoma elsewhere in the
stomach [9-11]. On the basis of these data, endoscopic re-
section has been recently recommended as the standard
treatment for GEDs after prior histologic confirmation of
dysplasia [12-14].
GED has traditionally been categorized into adenoma-
tous (intestinal/type I) and foveolar (gastric/type II) types,
on the basis of its morphologic characteristics [11,15,16].
Although prior studies have suggested that the foveolar
type is almost always low-grade [17,18], the findings of
our previous study indicated that foveolar type lesions are
more frequently high-grade when evaluated in a high-risk
population [19-21], and other studies have indicated that
the foveolar type is more commonly associated with
poorly-differentiated adenocarcinoma [3,22,23].
However, to date, there have been few studies on the
clinical characteristics of the 2 morphologically well-
recognized types of GED [15-19], especially in terms of
the long-term outcomes after endoscopic resection. Thus
we here aimed to elucidate the clinicopathologic charac-
teristics (including endoscopic findings) of each type in
patients having undergone endoscopic resection for GED,
and to investigate their long-term outcomes after endo-
scopic resection.
Methods
We retrospectively collected and evaluated data of endo-
scopic submucosal dissection (ESD) and endoscopic
mucosal resection (EMR) from our endoscopic database
system. From January 2008 to December 2009, 357 pa-
tients diagnosed with GED were treated by endoscopic
resection (ESD or EMR) at Pusan National University
Hospital, Busan, Korea. GEDs were morphologically cate-
gorized into adenomatous, foveolar, and hybrid types on
histologic examination. The patient characteristics (age,
sex, and H. pylori infection status), endoscopic findings
(location, macroscopic shape, and color of GEDs), and
histopathologic features (tumor size, presence of ulcer-
ation, and histologic grade) were examined according to
the morphological categorization of GEDs. Subsequently,
the short-term outcomes, such as en bloc and complete
resection rates; and the long-term outcomes, such as de-
tection of synchronous and metachronous lesions, includ-
ing GED or early gastric cancer (EGC), were analyzed
(Figure 1).
The study protocol was reviewed and approved by the
Institutional Review Board at Pusan National UniversityHospital (E-2013007), and written informed consent for
the endoscopic resection was obtained from all patients
before the procedure.
Endoscopic findings of GED
Locations of the GEDs were classified as longitudinal
(body/fundus or antrum/pylorus) and circular directions
(lesser curvature, greater curvature, anterior wall or pos-
terior wall). The macroscopic shapes of the lesions were
categorized as protruding (I), non-protruding and non-
excavated (II), or excavated (III). Type II lesions were
subclassified as slightly elevated (IIa), flat (IIb), or slightly
depressed (IIc) [24]. Next, all lesions were broadly classified
into 2 groups: protruded/elevated (I, IIa) and flat/depressed
(IIb, IIc, III) types. The colors of the lesions were catego-
rized as being either discolored or normal/reddish. Disco-
lored lesions were defined as endoscopically pale in color
as compared with the surrounding non-neoplastic mucosa,
as opposed to normal/reddish lesions, which were defined
as endoscopically reddish or similar in color to the sur-
rounding mucosa.
Histopathologic evaluation
All resected specimens were examined by the same expert
pathologist (D.Y. Park). All specimens were routinely fixed
in 10% buffered formalin, serially sectioned, embedded
in paraffin, cut into 2-mm sections, and stained with
hematoxylin and eosin as per standard protocol. Each
lesion was classified as being either adenomatous, foveolar,
or hybrid type according to its morphologic features, as
previously described [16,19]. Briefly, adenomatous GEDs
resemble colonic adenomas and are composed of large
tubules lined by basophilic columnar cells with hyper-
chromatic pencillate nuclei with pseudostratification,
and dense eosinophilic cytoplasm. Goblet and Paneth
cells are commonly seen in this form of GED (Figure 2).
Conversely, foveolar GEDs show cuboidal to columnar
cells with pale-to-clear cytoplasm and hyperchromatic
round-to-oval nuclei. Hyperplasia of the foveolar region
with irregular glandular branching and epithelial folding is
also frequently noted in the foveolar type, whereas Goblet
and Paneth cells are rarely identified (Figure 3). Cases of
GED showing at least 10% of a second phenotype were
classified as hybrid type (Figure 4). Each case was also
graded as either low- or high-grade according to previ-
ously defined and established criteria, including the pres-
ence of architectural complexity and cytologic atypia
[16,25]. Presence of ulceration was defined as rupture of
the muscularis mucosae or fibrosis in the submucosal
layer within the GEDs. En bloc resection was defined as
resection in a single piece as opposed to piecemeal resec-
tion (multiple segments). Complete resection was defined
as successful en bloc resection, with lateral and vertical
margins histologically free of neoplasm.
Figure 1 Flow chart of the patient inclusion in the study. GED, gastric epithelial dysplasia.
Figure 2 Representative endoscopic and histologic findings of an
adenomatous-type gastric epithelial dysplasia. (A) An elevated lesion
with nodular changes is seen at the lesser curvature of the lower body.
(B) On histology, tubules lined by columnar cells with hyperchromatic,
pencillate nuclei with pseudostratification, and little branching or
irregularity are noted (hematoxylin and eosin stain, ×200).
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Patient follow-up was based on only endoscopy. The starting
date of the follow-up was defined as the date of endoscopic
resection (ESD or EMR), and the end of the follow-up was
the last date of follow-up endoscopy. Follow-up endoscopy
was performed at 6 months after ESD or EMR, and annually
thereafter. Biopsy was performed at sites suspicious of har-
boring synchronous or metachronous lesions. A synchron-
ous lesion, including GED and EGC, was defined as either a
concomitant lesion at the time of ESD/EMR, or a lesion de-
tected within a 12-month period after ESD or EMR [26,27].
For patients with initial synchronous lesions, the most dys-
plastic lesion was considered the main lesion. Similarly in
cases of initially detected multiple lesions with the same
histology, the largest lesion was considered the main lesion.
A metachronous lesion, including GED and EGC, was de-
fined as a lesion diagnosed 12 months after ESD or EMR
for the primary lesion, and located in a different part of the
Figure 3 Representative endoscopic and histologic findings of a
foveolar-type gastric epithelial dysplasia. (A) A slightly depressed
lesion is seen at the lesser curvature of the antrum. (B) On histology,
cuboidal to columnar cells with pale cytoplasm and basally located
ovoid nuclei with branching, budding and a cribriform pattern are
observed (hematoxylin and eosin stain, ×200).
Table 1 Clinicopathologic characteristics of patients with




(n = 167) (n = 103) (n = 87)
Age (years,
mean ± SD)
64.0 ± 9.2 60.8 ± 9.0 62.9 ± 9.3 0.732
Gender,
male:female
117:50 70:33 59:28 0.907




Body/fundus 98 (58.7) 26 (25.2) 26 (29.9)
Antrum/pylorus 69 (41.3) 77 (74.8) 61 (70.1)
Location (circular) 0.023
LC 79 (47.3) 32 (31.1) 32 (36.8)
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recurrence was defined as GED detected at the site of an
endoscopic resection scar.
Statistical analysis
Quantitative data (age and tumor size) were expressed by
mean and standard deviation (SD). Differences in clinico-
pathologic features among the 3 GED types were evalu-
ated by using the one-way analysis of variance followed by
Tukey’s post-hoc test for continuous variables, and the χ2
test or Fisher’s exact test for categorical variables. Short-
term outcomes (en bloc and complete resection rates) and
long-term outcomes (incidence of synchronous and meta-
chronous lesions) after endoscopic resection according to
the GED type and histologic grade were analyzed by using
the χ2 test or Fisher’s exact test. A p-value of < 0.05 was
considered statistically significant. Statistical calculations
were performed using SPSS version 17.0 software for
Windows (SPSS, Chicago, IL, USA).
Results
Clinicopathologic characteristics of the GED patients
The clinicopathologic characteristics of the enrolled 357
patients are summarized in Table 1. The patientsFigure 4 Representative endoscopic and histologic findings of a
hybrid-type gastric epithelial dysplasia. (A) A nodular lesion with
slight central depression is seen at the anterior wall of the antrum.
(B) On histology, features of both foveolar-type and adenomatous-
type dysplasias are observed (hematoxylin and eosin stain, ×200).included 246 men and 111 women, with a mean age of
62.8 years (range, 36–85 years). On the basis of the mor-
phological features of GED on histologic examination,
the patients were divided into 3 groups: adenomatous
(n = 167), foveolar (n = 103), and hybrid type (n = 87).
There was no history of familial polyposis syndrome in
any patient. All 3 types of GED occurred more commonly
in men than in women, and there were no statistical sig-
nificant differences in terms of patient age, gender, and
prevalence of H. pylori infection among the 3 morphologic
groups of GED (p = 0.732, p = 0.907, and p = 0.284,
respectively).
When the locations of the GEDs were divided accord-
ing to the longitudinal and circular directions, adenoma-
tous type lesions were found to be more frequently located
in the body/fundus and in the lesser curvature side than
the foveolar and hybrid types (58.7% vs. 25.2% and 29.9%,Elevated/
protruded
101 (60.5) 39 (37.9) 33 (37.9)
Flat/depressed 66 (39.5) 64 (62.1) 54 (62.1)
Color < 0.001
Discolored 118 (70.1) 22 (21.4) 33 (37.9)
Normal/reddish 49 (29.9) 81 (78.6) 54 (62.1)
Ulceration 4 (2.4) 7 (6.8) 4 (4.6) 0.211
Size (cm,
mean ± SD)
1.5 ± 0.9 1.2 ± 0.7 1.8 ± 2.5 0.093
Histologic grade 0.002
Low 127 (76.0) 66 (64.1) 48 (55.2)
High 40 (24.0) 37 (35.9) 39 (44.8)
Values are expressed as n (%).
LC, lesser curvature; GC, greater curvature; AW, anterior wall; PW,
posterior wall.
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ively). On macroscopic examination of the GEDs, a
flat/depressed shape was more commonly observed in
the foveolar and hybrid types than in the adenomatous
type (62.1% and 62.1% vs. 39.5%, p < 0.001), whereas
discoloration was observed more frequently in the ad-
enomatous type than in the foveolar and hybrid types
(70.1% vs. 21.4% and 37.9%, p < 0.001).
The mean size of the foveolar type lesions was smaller
than that of the adenomatous and hybrid types (1.2 cm
vs. 1.5 cm and 1.8 cm, respectively), although this was
not statistically significant (p = 0.093). Ulceration was
rare in all 3 types (p = 0.211). In terms of the histologic
grade, the foveolar and hybrid types showed high-
grade histology significantly more frequently than
adenomatous type lesions (35.9% and 44.8% vs. 24.0%,
p = 0.002).Short-term outcomes of patients with GED having
undergone endoscopic resection
ESD and EMR were performed in 21 (5.9%) and 336
(94.1%) lesions, respectively (Table 2). The en bloc and
piecemeal resection rates were 97.8% (349/357), and
2.2% (8/357), respectively. Of the 349 en bloc-resected
lesions, 51 lesions were found to be incomplete resec-
tions, owing to lateral involvement of the tumor cells in
46 cases, and impossible margin assessment caused by
the cauterization artifact in 5 cases. Accordingly, the
complete resection rate was 83.5% (298/357). Interestingly,
the complete resection rate in adenomatous type lesions
was significant lower than that in the foveolar and hybrid
types (78.4% vs. 84.5% and 92.0%, p = 0.022).Table 2 Short-term outcomes of patients with gastric




(n = 167) (n = 103) (n = 87)
En bloc
resection
EMR 7/7 (100) 11/11 (100) 3/3 (100) 1.000
ESD 155/160 (96.9) 89/92 (96.7) 84/84 (100) 0.255
Total 162/167 (97.0) 100/103 (97.1) 87/87 (100) 0.267
Complete
resection
EMR 4/7 (57.1) 9/11 (81.8) 3/3 (100) 0.282
ESD 127/160 (79.4) 78/92 (84.8) 77/84 (91.7) 0.044
Total 131/167 (78.4) 87/103 (84.5) 80/87 (92.0) 0.022
Values are expressed as n (%).
EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection.Long-term outcomes of patients with GED having
undergone endoscopic resection
Of the 357 patients, we excluded 208 patients who were
followed for <1 year, resulting in 149 patients who
underwent endoscopic resection for GED being included
in our long-term outcome analysis (Table 3). Synchron-
ous lesions were observed in 31 patients (20.8%) during
the study period (18 GEDs and 13 EGCs). There was no
statistically significant difference in the incidence of syn-
chronous lesions according to the morphological types
(p = 0.088). In all 18 patients with synchronous GEDs,
complete resection was achieved by ESD. Moreover, all
13 patients with EGC underwent ESD, and all resected
carcinomas were differentiated-type adenocarcinomas lim-
ited to the mucosa without lymphovascular involvement: 12
(92.3%) were well-differentiated tubular adenocarcinomas
and 1 (7.7%) were moderately differentiated. However, one
patient underwent additional gastrectomy because of incom-
plete resection after ESD.
The overall incidence of metachronous lesions after
endoscopic treatment was 20.1% (30/149) during a median
follow-up period of 37.3 months (range, 12–70 months);
of these, the incidence of metachronous GED and carcin-
oma was 14.8% (22/149) and 5.4% (8/149), respectively.
There was no statistically significant difference in the
incidence of metachronous lesions according to the
morphological types (p = 0.898). The median interval
from endoscopic resection of GED to detection of the
first metachronous neoplasm was 34 months (range,
15–69 months). In all 22 patients with metachronous
GEDs, complete resection was achieved by ESD. In the
8 patients with metachronous carcinoma, 7 patients under-
went a second ESD, and all resected carcinomas were
found to be differentiated-type adenocarcinomas limited
to the mucosa without lymphovascular involvement: 4
(57.1%) were well-differentiated tubular adenocarcinomas
and 3 (42.9%) were moderately differentiated. One patient
with carcinoma underwent surgery because of poorlyTable 3 Long-term outcomes of patients with gastric
epithelial dysplasia having undergone endoscopic resection
Morphologic type p-value
Adenomatous Foveolar Hybrid
(n = 68) (n = 46) (n = 35)
Synchronous
lesions
19 (27.9) 5 (10.9) 7 (20) 0.088
GED 11 (16.2) 4 (8.7) 3 (8.6) 0.372
Cancer 8 (11.8) 1 (2.2) 4 (11.4) 0.166
Metachronous
lesions
13 (19.1) 9 (19.6) 8 (22.9) 0.898
GED 10 (14.7) 5 (10.9) 7 (20) 0.518
Cancer 3 (4.4) 4 (8.7) 1 (2.9) 0.459
Values are expressed as n (%).
GED, gastric epithelial dysplasia.
Table 4 Clinicopathologic characteristics of lesions in








(n = 18) (n = 22) (n = 40)
GED type
A→ A/F/H 8/2/1 9/0/1 17/2/2
F→ A/F/H 1/3/0 4/1/0 5/4/0
H→ A/F/H 1/1/1 3/1/3 4/2/4
Same type 12 (66.7) 13 (59.1) 25 (62.5)
Location
Body→ Body/Antrum 3/4 6/5 9/9
Antrum→ Body/Antrum 5/6 3/8 8/14
Same location 9 (50.0) 14 (63.6) 23 (57.5)
Macroscopic shape
I&IIa→ I&IIa/IIb&IIc 9/5 7/8 16/13
IIb&IIc→ I&IIa/IIb&IIc 2/2 2/5 4/7
Same shape 11 (61.1) 12 (54.5) 23 (57.5)
Values are expressed as n (%).
GED, gastric epithelial dysplasia; A, adenomatous type; F, foveolar type;
H, hybrid type.
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addition, there were no statistical significant differences
in the incidence of synchronous and metachronous le-
sions according to the histologic grading of GEDs high-
grade vs. low-grade, 16.0% vs. 23.2%, p = 0.311; 24.0%
vs. 18.2%, p = 0.403, respectively).
During the follow-up period, local recurrence occurred
in 2 of 59 lesions with incomplete resection. One recur-
rence occurred 29 months after ESD for hybrid GED,
and the other, 55 months after ESD for adenomatous
GED. The morphologic type of both recurrent lesions
was adenomatous. In these 2 lesions, additional endo-
scopic treatment (argon plasma coagulation) was per-
formed, and no further recurrence was noted during the
follow-up period.
Incidence of gastric cancer in patients with GED
Of 149 patients with GEDs, gastric cancer was detected
in 21 (14.1%) patients, of whom 13 and 8 had synchron-
ous and metachronous cancer, respectively. All gastric
cancers were endoscopically diagnosed as EGC. Gastric
cancer was detected in 11 (16.2%), 5 (10.9%), and 5
(14.3%) patients with adenomatous, foveolar, and hybrid
type lesions, respectively. (p = 0.726).
Clinicopathologic similarities of GEDs in patients with
multiple GEDs
The clinicopathologic characteristics of patients with mul-
tiple GEDs (n = 40) are shown in Table 4. Approximately
two-thirds of the lesions showed similarities in terms of
the morphologic type, location, and macroscopic shape
compared to the primary lesions.
Discussion
The increased use of esophagogastroduodenoscopy re-
cently has resulted in an increase in the diagnosis of
GED and the subsequent endoscopic treatments of this
lesion. Although several studies have previously reported
on the clinical and endoscopic characteristics according
to the morphologic types [15-19], numerous questions
still remain concerning the clinical significance of each
type of GEDs, including the long-term follow-up out-
comes. In addition, these previous studies included only
relatively small numbers of cases. In the present study,
we compared the clinicopathologic characteristics of GEDs
according to the morphologic types and evaluated the
long-term follow-up outcomes of each type (synchronous
and metachronous lesions).
In the present study, we found that GED was more
prevalent in men (male:female ratio, 2.2:1), which is simi-
lar to the results of previous studies [6,7]. However, there
was no difference in the male:female ratio according to
the morphologic types.The natural history of H. pylori infection in the stom-
ach is to go through a cascade of events, including non-
atrophic gastritis, atrophic gastritis, intestinal metaplasia,
dysplasia, and finally cancer [28,29]; and the presence of
H. pylori infection has showed to be associated with an
increased risk of progression to dysplasia or gastric can-
cer, with an odds ratio of 1.8 [30]. In the present study,
the frequency of H. pylori infection was 79.6% in pa-
tients with GED, which is substantially higher than the
frequency reported in the general population (59.6%)
[31,32]. However, there was no difference in the fre-
quency of H. pylori infection according to the morpho-
logic types. Although this was not an epidemiological
study, our results support the close relationships be-
tween H. pylori infection and GED, irrespective of mor-
phologic types.
It has been well established that GEDs occur through-
out the stomach, with a slight antral predominance, and
that they can range in size from a few millimeters to sev-
eral centimeters [33-35], which is similar to our results
(antrum:body ratio, 1.4:1). However, in this study, we
moreover demonstrated that GEDs show distinct endo-
scopic and histopathologic features according to the
morphologic types. We found that adenomatous GEDs
were more likely to occur in the gastric body and lesser
curvature side of the stomach, whereas foveolar GEDs
were mainly located in the gastric antrum and non-lesser
curvature side of the stomach. In addition, foveolar GEDs
were smaller, and were normal/red colored and showed a
flat/depressed shape more frequently than adenomatous
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more likely to show high-grade dysplasia than were aden-
omatous GEDs, which is consistent with the results of our
previous study [19]. An association between macroscopic
shape and histologic grade has been suggested in a previ-
ous study [36], with GEDs with a depressed shape showing
higher proportions of reddish color and severe atypia or
carcinoma compare to GEDs with non-depressed shapes.
These findings concur with our findings that foveolar
GEDs predominantly showed normal/reddish color, flat/
depressed shape, and high-grade morphology. Further-
more, in the present study, of the 8 metachronous gastric
cancers detected during the follow-up period, only one
case was a signet ring cell carcinoma, and this occurred in
a patient with a foveolar GED, which is consistent with
the results of previous studies suggesting that the foveolar
type is associated with high-grade histologic features and
poorly-differentiated adenocarcinomas [3,19,22,23]. We
speculate that these differences observed between GED
types might reflect differences in the tumorigenesis of
each GED type. However, further large-scale studies are
required to clarify this.
In the present study, the complete resection rate in ad-
enomatous type lesions was 78.4%, which was signifi-
cantly lower than in foveolar and hybrid type lesions
(84.5% and 92.0%, respectively). We hypothesize that the
cause for this phenomenon may be because most GEDs
with adenomatous type were low-grade and considered
more discrete lesions owing to their whitish color and
elevated/protruded morphology compared to those of
the other 2 types, and that, consequently the endosco-
pists may have tended to perform endoscopic resection
less carefully, such as marking closely around the lesion.
Treatment strategies for incomplete resection after
endoscopic resection of GEDs have not been well estab-
lished. Considering the indolent behavior of GED, we
performed annual follow-up for incompletely resected
GEDs. During the follow-up period, local recurrence oc-
curred in only 2 of 59 lesions with incomplete resection.
In these 2 lesions, additional argon plasma coagulation
was performed, after which further recurrence did not
occur. Local recurrence is generally caused by small
remnants being left on the margins after endoscopic re-
section. However, in the present study, the recurrence
rate in cases with incomplete resection was very low
(3.4%). The reason for this might be the uncertainty of
judging a cut margin because of the burning effect of
electrosurgical devices on the residual tumor cells in posi-
tive margins. Our results suggest that close endoscopic
surveillance without additional treatment may be an ac-
ceptable option for GEDs with incomplete resection.
A major concern in the management of GEDs is the in-
ability to predict in which patient cancer will occur. Because
it is often difficult to distinguish between the histologicgrades from endoscopic findings, and because there are
commonly discrepancies between the pre-endoscopic
resection and post-endoscopic resection diagnoses [37-39],
treatment modalities for GEDs ensuring accurate diagnosis
and potentially curative resection, such as ESD or EMR,
are needed. However, ESD or EMR can only remove gas-
tric neoplasms in the part of the gastric mucosa containing
the visible lesion with minimal surrounding normal tissue.
Therefore, there is always a risk of occurrence of syn-
chronous or metachronous gastric neoplasms in other
sites, as GEDs are known to be indicators of an increased
risk of synchronous adenocarcinoma elsewhere in the
stomach [12,40].
One or more primary carcinomas can coexist at the
time of diagnosis (synchronous), or develop consequently
(metachronous), sometimes years after resection of the
first GEDs. In the present study, gastric cancers were
found on 21 out of 149 patients with available long-term
follow-up information (14.1%). This rate is very high
compared to the incidence of gastric cancer in the gen-
eral population (0.3%) and individuals participating in
health-screening programs (0.44%) [41,42]. Conversely,
there were no cases of tumor-related deaths due to syn-
chronous or metachronous cancer in this study. The
prognosis in patients with gastric cancer depends largely
on the stage at diagnosis [43], and in the present
study, the median time interval from endoscopic re-
section of GED to metachronous cancer was approxi-
mately 34 months, and all synchronous and metachronous
cancers were found at an early stage. Although the pur-
pose of this study is to evaluate differences in the follow-
up according to the three histologic types, we added an
analysis based on grading of the lesions (low- and high-
grade). There were no statistically significant differences in
the incidence of synchronous and metachronous lesions.
Despite numerous reports on the characteristics of
synchronous and metachronous lesions after endoscopic
treatment, the appropriate surveillance strategies after gas-
tric endoscopic treatment remain unclear. On the basis of
our results, we believe that the meticulous endoscopic
follow-up in patients with GEDs after endoscopic resec-
tion may lead to the diagnosis of gastric cancer at an early
stage, thus improving the survival rate, and regular endo-
scopic examinations and histologic controls (for example
annually) are advisable.
Furthermore, about two-thirds of synchronous and
metachronous GEDs were found at similar locations as
the primary lesion in the present study. Hence, careful
observation around the site of the primary lesion may be
helpful for detecting synchronous or metachronous le-
sions and to reduce the risk of overlooking these lesions
during follow-up endoscopy.
To our knowledge, this is the largest study to show
morphologic characterization of GEDs to date, and the
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after endoscopic resection according to morphologic
types. However, our study has some limitations. First,
there may have been a potential selection bias resulting
from the retrospective nature of this single-center study.
In our study, many patients were not included in the ana-
lysis of long-term outcomes because they did not undergo
endoscopy at our hospital and hence their results were not
available. The reasons for loss to follow-up in this study
could be explained by the fact that after endoscopic treat-
ment of GEDs, some patients choose to undergo follow-
up endoscopy at other hospitals for various reasons such
as the cost of endoscopy, the distance to the hospital, per-
sonal reasons, or the National Cancer Screening Program.
In Korea, the National Cancer Screening Program pro-
vides endoscopy free-of-charge every 2 years for individ-
uals older than 40 years. If the data for the patients lost to
follow-up within 12 months of ESD had been included in
our analysis, the study may have shown different results.
Second, the follow-up period (median 37.3 months) was
relatively short for a study of long-term results, and
further large-scale prospective studies involving a greater
number of patients and longer follow-up periods will be
needed to obtain more exact information on the clinico-
pathologic features of each subtype of GEDs and the
long–term outcomes of GEDs after endoscopic resection.
Third, we classified GEDs as adenomatous, foveolar, or
hybrid types according to their morphologic features
only; rthese types were determined by a single expert
gastrointestinal pathologist. However, histologic evalu-
ation alone, even if performed by an expert pathologist,
may fail to evaluate the morphologic type correctly.
Therefore, it could have been more accurate and more ob-
jective if at least two expert pathologists had analyzed the
morphologic type. Furthermore, in such situations, mucin
expression patterns as determined by immunohistochem-
istry are helpful to obtain detailed information on the
differentiation of GEDs. Although we did not evaluate
the mucin expression patterns in the present study, we
previously found that foveolar and hybrid types are
more often positive for MUC5AC, whereas the aden-
omatous type is more often positive for CD10 [19].
Since there results have already been reported previ-
ously, we did not perform immunohistochemical ana-
lysis to investigate the concordance of histologic and
immunohistochemical classification of GEDs in the
present study.
Conclusions
Our study demonstrated the clinicopathologic characteris-
tics of GEDs and long-term follow-up results after endo-
scopic resection according to morphologic categorization.
Foveolar type lesions were found to have a depressed shape,
smaller size, normal/reddish color, and antral predominanceand to be high-grade lesions significantly more frequently
than adenomatous type lesions. Irrespective of the morpho-
logic type, synchronous and metachronous lesions were
commonly found after endoscopic resection of GEDs.
Therefore, close follow-up surveillance after endoscopic re-
section of GEDs should be performed for all patients, and
endoscopists should make note of similarities among mul-
tiple lesions.
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